Brief: Sun Pharma Approves Issuance Of NCDs Worth Up To 100 Billion Rupees
12/10/2026 15:28
BRIEF-Sun Pharma Approves Issuance Of NCDs Worth Up To 100 Billion Rupees Oct 12 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - APPROVES ISSUANCE OF NCDS WORTH UP TO 100 BILLION RUPEES
Source text: ID:nBSE71zLck
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
India New Issue-Sun Pharma accepts bids for bond issues, bankers say
Brief: Sun Pharma Says Unloxcyt Receives Category 2A Designation In NCCN Guidelines For LACSCC
India New Issue-Sun Pharma to issue over five-year bonds, bankers say
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say